Reported side effects may include: Nausea Flushing Appetite suppression Blood pressure changes Darkening of freckles or moles Potential melanoma concerns Excessive UV exposure may still increase the risk of skin damage and skin cancer
Conversely, those with FTO rs9939609 risk variants may struggle with hunger signals after stopping and benefit from extended therapy, a lower-dose maintenance regimen, or PlexusDx's GLP-Squared combination therapy for dual-pathway reinforcement
Carbohydrate, fat and protein intakes, as well as bile acids, can stimulate the secretion of GLP-1 by intestinal L-cells (Gribble and Reimann, 2021)
GLP-1 medications can suppress appetite and worsen gastrointestinal symptoms, increasing the risk of malnutrition or sarcopenia issues already prevalent in older CKD patients
Why Tirzepatide's Dual Mechanism Works for Menopausal Weight Gain Two powerful pathways working togetherindependent of your reproductive hormones